Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Liposarcoma, Myxoid 1

Interventions

Cyclophosphamide 5 Trabectedin 3 Radiation Dose Hypofractionation 3 fludarabine 2 selinexor 1 pazopanib 1 palbociclib 1 mirdametinib 1 itacitinib 1 fludarabine phosphate 1 cytochrome C synthetase 1 baricitinib 1 aldesleukin 1 X-Rays 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sirolimus 1 Radiotherapy 1 Proton Therapy 1 Pioglitazone 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Interferon-gamma 1 Ifosfamide 1 INCB039110 1 Doxorubicin 1 Diathermy 1 Biopsy 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liposarcoma, Myxoid × cytochrome C synthetase × Clear all

NCT02106312 2021-08-04

DOREMY

The Netherlands Cancer Institute

Phase 2 Unknown

Sarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡